Comparison of Innovative and Conventional Methods in Biosimilar Bridging Studies with Multiple References
Annpey Pong,1 Susan S Chow,2 Shein-Chung Chow3 1Biostatistics, Merck & Co Inc., Rahway, NJ, USA; 2Internal Medicine, The Wright Center for Community Health, Scranton, PA, USA; 3Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC, USACorrespondence: Annp...
Saved in:
Main Authors: | Pong A, Chow SS, Chow SC |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2024-12-01
|
Series: | Biologics: Targets & Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/comparison-of-innovative-and-conventional-methods-in-biosimilar-bridgi-peer-reviewed-fulltext-article-BTT |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nonclinical Similarity of the Biosimilar Candidate ABP 938 with Aflibercept Reference Product
by: Neungseon Seo, et al.
Published: (2024-11-01) -
A prospective, randomized, double-blind, comparative clinical study of efficacy and safety of a biosimilar adalimumab with innovator product in patients with active rheumatoid arthritis on a stable dose of methotrexate
by: Prasad Apsangikar, et al.
Published: (2018-01-01) -
Biosimilar biological drugs in the treatment of inflammatory bowel diseases
by: Magdalena Kaniewska, et al.
Published: (2019-12-01) -
Assessing Protein Content and Dimer Formation in the Bevacizumab Reference Product and Biosimilar Versions Marketed in Spain
by: Alexis Oliva, et al.
Published: (2024-11-01) -
Perceptions of Biosimilars Among Healthcare Providers in Saudi Arabia
by: Mohammed Alqahtani, et al.
Published: (2024-11-01)